Carlyle Group Inc.
13F Reported Value
ⓘ$10.0B
Holdings
19
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Carlyle Group Inc. disclosed 19 positions worth $10.0B in its Form 13F-HR for Q2 2026, led by $MDLN (Medline Inc.) at 73.8% of the equity portfolio, followed by $SARO and $PHAT. During the quarter the fund opened 3 new positions and exited 4 — including a new stake in $REPX and a full exit from $CUBE. The portfolio is most concentrated in Healthcare (74.2% of disclosed assets). All figures are sourced directly from Carlyle Group Inc.’s Form 13F-HR filing with the SEC under CIK 1527166.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 62.5#705
Quality
$7.4B187,083,713 sh - 59.5#924
Quality
$2.5B84,587,035 sh - 40.9#2,083
Quality
$37.9M3,496,808 sh - 68.9
Quality
$20.0M662,900 sh - —
Quality
$16.4M2,362,447 sh - 28.2
Quality
$5.4M6,234,252 sh - —
Quality
$2.1M38,620 sh - 38.8
Quality
$1.6M2,343,750 sh - —
Quality
$1.6M184,295 sh - 41.7
Quality
$1.4M107,214 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| 62.5#705 | $7.4B | 187,083,713 | |
| 59.5#924 | $2.5B | 84,587,035 | |
| 40.9#2,083 | $37.9M | 3,496,808 | |
| 68.9 | $20.0M | 662,900 | |
| — | $16.4M | 2,362,447 | |
| 28.2 | $5.4M | 6,234,252 | |
| — | $2.1M | 38,620 | |
| 38.8 | $1.6M | 2,343,750 | |
| — | $1.6M | 184,295 | |
| 41.7 | $1.4M | 107,214 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Carlyle Group Inc.'s 19 positions.
Showing top 10 of 19 holdings.
Sector Allocation
Healthcare
$7.4B
Industrials
$2.5B
Real Estate
$20.0M
Technology
$17.3M
Consumer Staples
$1.2M
Energy
$818,054
Financials
$474,625
Full Holdings — Carlyle Group Inc. (Q2 2026)
All 19 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Medline Inc. | $7.4B | 73.8% | +0% | 62.5 | |
| 2 | StandardAero, Inc. | $2.5B | 25.3% | +0% | 59.5 | |
| 3 | Phathom Pharmaceuticals, Inc. | $37.9M | 0.4% | +0% | 40.9 | |
| 4 | Invitation Homes Inc. | $20.0M | 0.2% | -0% | 68.9 | |
| 5 | Pony AI Inc. | $16.4M | 0.2% | +0% | — | |
| 6 | Getty Images Holdings, Inc. | $5.4M | 0.1% | +0% | 28.2 | |
| 7 | SPRUCE BIOSCIENCES, INC. | $2.1M | 0.0% | +0% | — | |
| 8 | SunPower Inc. | $1.6M | 0.0% | +441% | 38.8 | |
| 9 | Adicet Bio, Inc. | $1.6M | 0.0% | +0% | — | |
| 10 | FORWARD AIR CORP | $1.4M | 0.0% | +0% | 41.7 | |
| 11 | OnKure Therapeutics, Inc. | $1.2M | 0.0% | +0% | — | |
| 12 | Krispy Kreme, Inc. | $1.2M | 0.0% | +0% | 33.2 | |
| 13 | Q32 Bio Inc. | $769,020 | 0.0% | -95% | 36.4 | |
| 14 | Riley Exploration Permian, Inc. | $530,387 | 0.0% | NEW | 63.7 | |
| 15 | Nebius Group N.V. | $509,810 | 0.0% | NEW | — | |
| 16 | Robinhood Markets, Inc. | $474,625 | 0.0% | +40% | 82.1 | |
| 17 | Jasper Therapeutics, Inc. | $448,866 | 0.0% | +0% | — | |
| 18 | N-able, Inc. | $343,996 | 0.0% | +0% | 48.9 | |
| 19 | Ramaco Resources, Inc. | $287,667 | 0.0% | NEW | 20.2 |
New Positions (3)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Carlyle Group Inc. including:
Track Carlyle Group Inc.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Carlyle Group Inc. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Carlyle Group Inc.
13F Pro is an AI hedge fund tracker and stock research platform. For Carlyle Group Inc. (SEC CIK: 1527166), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Carlyle Group Inc.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.